A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD.
OBJECTIVE
To determine whether an algorithm for the treatment of attention-deficit/hyperactivity disorder (ADHD) can be implemented in a community mental health center.


METHODS
Fifty child and adolescent patients at Texas community mental health centers who met criteria for ADHD were treated according to an algorithm-based disease management program for ADHD. Psychiatrists were trained in the use of the algorithm, and each subject underwent a baseline assessment consisting of a structured interview and standardized rating scales. Subjects were monitored for 4 months. At the end of treatment, the psychiatrists completed the Clinical Global Impression Scale (CGI) and the baseline rating scales were repeated. The primary variables of interest were psychiatrist and family adherence to the algorithm. To examine impact on treatment outcome, the CGI of the algorithm subjects was compared with CGIs based on chart reviews of 118 historical controls.


RESULTS
Psychiatrists implemented the major aspects of the algorithm, but the detailed tactics of the algorithm (use of fixed titration of stimulants) were less well adhered to.


CONCLUSIONS
An algorithm for the treatment of ADHD can be implemented in a community mental health center.
Pliszka
Steven R
SR
University of Texas Health Science Center at San Antonio, Texas 8229-3900, USA. pliszka@uthscsa.edu
Lopez
Molly
M
Crismon
M Lynn
ML
Toprac
Marcia G
MG
Hughes
Carroll W
CW
Emslie
Graham J
GJ
Boemer
Christine
C
D000293:Adolescent; D000465:Algorithms; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D003155:Community Mental Health Centers; D019317:Evidence-Based Medicine; D005240:Feasibility Studies; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
D000697:Central Nervous System Stimulants; D008774:Methylphenidate